Literature DB >> 15384155

Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry.

Robert Plumb1, Jose Castro-Perez, Jennifer Granger, Iain Beattie, Karine Joncour, Andrew Wright.   

Abstract

Ultra-performance liquid chromatography (UPLC) utilizes sub-2 microm particles with high linear solvent velocities to effect dramatic increases in resolution, sensitivity and speed of analysis. The reduction in particle size to below 2 microm requires instrumentation that can operate at pressures in the 6000-15,000 psi range. The typical peak widths generated by the UPLC system are in the order of 1-2 s for a 10-min separation. In the present work this technology has been applied to the study of in vivo drug metabolism, in particular the analysis of drug metabolites in bile. The reduction in peak width significantly increases analytical sensitivity by three- to five-fold, and the reduction in peak width, and concomitant increase in peak capacity, significantly reduces spectral overlap resulting in superior spectral quality in both MS and MS/MS modes. The application of UPLC/MS resulted in the detection of additional drug metabolites, superior separation and improved spectral quality. Copyright 2004 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2004        PMID: 15384155     DOI: 10.1002/rcm.1627

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  37 in total

Review 1.  ADME of biologics-what have we learned from small molecules?

Authors:  Thomayant Prueksaritanont; Cuyue Tang
Journal:  AAPS J       Date:  2012-04-07       Impact factor: 4.009

2.  Ultra performance liquid chromatography (UPLC) further improves hydrogen/deuterium exchange mass spectrometry.

Authors:  Yan Wu; John R Engen; William B Hobbins
Journal:  J Am Soc Mass Spectrom       Date:  2006-01-10       Impact factor: 3.109

3.  Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum.

Authors:  Anders Nordström; Grace O'Maille; Chuan Qin; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-05-15       Impact factor: 6.986

Review 4.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

Review 5.  Metabolomics: moving to the clinic.

Authors:  Anders Nordström; Rolf Lewensohn
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-28       Impact factor: 4.147

6.  The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery.

Authors:  Thomas O Metz; Qibin Zhang; Jason S Page; Yufeng Shen; Stephen J Callister; Jon M Jacobs; Richard D Smith
Journal:  Biomark Med       Date:  2007-06       Impact factor: 2.851

7.  Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 8.  Metabolomics: A Primer.

Authors:  Xiaojing Liu; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2017-02-11       Impact factor: 13.807

9.  Label-free quantitative proteomics analysis of etiolated maize seedling leaves during greening.

Authors:  Zhuo Shen; Ping Li; Rui-Juan Ni; Mark Ritchie; Chuan-Ping Yang; Gui-Feng Liu; Wei Ma; Guan-Jun Liu; Ling Ma; Shu-Juan Li; Zhi-Gang Wei; Hong-Xia Wang; Bai-Chen Wang
Journal:  Mol Cell Proteomics       Date:  2009-08-07       Impact factor: 5.911

10.  Quantitative determination of betamethasone sodium phosphate and betamethasone dipropionate in human plasma by UPLC-MS/MS and a bioequivalence study.

Authors:  Man-Yun Chen; Yong-Jun Tang; Yi-Cheng Wang; Chong-Zhi Wang; Chun-Su Yuan; Yao Chen; Zhi-Rong Tan; Wei-Hua Huang; Hong-Hao Zhou
Journal:  Anal Methods       Date:  2016-03-29       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.